Diabetes mellitus Flashcards
Screening
- >40 yo/ 3 years with AUSDRISK 2. All ATSI >18yo 3. High risk FG/year
High risk groups on screening
- IFG/IGT 2. >40 w/ BMI >30 3. Women w/ history of GDM/PCOS 4. Pacific islanders >35 5. Previous CV event 6. Antipsychotic
Risk of developing diabetes w/ AUSDRISK scores
- For scores of 12–15, 1 in 14 will develop 2. 16–19, 1 in seven will develop diabetes. 3. 20 and above, 1 in three will develop diabetes.
At what AUSDRISK is increased risk
When score is >12
History
- Symptoms: Glycosuria: polyuria, polydipsia, polyphagia, weight loss hyperglycaemia: malaise/fatigue, altered vision, delayed wound healing. Bacterial infections Loss of sensation 2. Risk assessment: Risk factors for complications: personal or family history of CVD, smoking, hypertension, dyslipidaemia, mental health problems 3. SNAP 4. Other aspects of history age, family history, cultural group, overweight, physical inactivity, hypertension obstetric history of large babies or GDM medication causing hyperglycaemia personal or family history of haemochromatosis personal or family history of other autoimmune diseases (e.g. hypothyroidism or hyperthyroidism). 5. Complications cardiovascular symptoms, neurological symptoms, bladder and sexual function, foot and toe problems and any recurrent infections
Physical examination
General: adiposity, pigmentation, endocrinological features, acanthosis nigricans, skin tags, infections CV system, including postural BP Eyes->with fundoscopy, nerve palsies Abdomen->hepatomegaly Feet Urinalysis Evidence of impaired glucose tolerance: obesity, acanthosis nirgicans, hirsutism, skin tags, menstrual irregularities
Investigations
Serum glucose: random and fasting HbA1C UEC LFTs Urine protein:creatinine, albumin Fasting lipids FBE Urine Consider opthalmology, podiatry
Diagnostic criteria
Fasting blood glucose >7 Random blood glucose >11.1= diagnostic FBG 5.5-6.9/RBG5.5-11/ HbA1c >6.5–>consider
DIagnostic criteria post OGTT
FBG >7 mmol/L, BG 2h ≥11 mmol/L= diagnostic FBG
Management overview for T2DM
- Lifestyle modification 2. Refer to allied health professionals 3. Medication 4. Problem areas in Diabetes tool 5. Vaccinations 6. General support, psychosocial 7. Management of co-morbidities 8. Driving 9. Annual diabetes screen, care plan 10. BP, Lipids->Statin and ACEi 11. BMI, kidney and liver function
Lifestyle modification
- Smoking cessation 2. Alcohol within guidelines (risk hypoglycemia) 3. Weight->5-10% loss= prevention, delay, control 4. Diet->balanced, wholefoods, mediterrenean 5. Physical activity
Advice on physical activity
- Minimum 210 minutes/week 2. No more than 2 consequetive days without activity 3. Strength training included 4. 6-12 hour hypoglycemic delay if on insulin or sulphonylureas 5. Monitor BG before, during and post activity 6. If on insulin or sulphonylureas be mindful of delayed hypoglycemia 6-12 hours post activity
Vaccinations
- Influenza annually 2. Tetanus booster after 50 3. Pneumococcal Non-ATSI single dose then another >65, or 10 years after first dose (whichever is first) Non ATSI >65, ATSI >50->single dose then repeat in 5 years
Management algorithm
- Lifestyle + metformin (or sulfonylurea if cannot tolerate) 2. Stop rule! 3-6 months r/v->if not achieved add Sulfonylural, thiazolinedione, DPP4 inhibitor, acarbose, Injectable insulin or GLP1 agonist 3. Stop rule! 3-6 months r/v->add/change If after 6 mo and appropriate titration not achieve Stop. Check health literacy, lifestyle changes, review non-adherence, occult infection? Ask about hypoglycemia and side effects 4. Add a. Insulin (continue MF if tolerated). If glycosuric symptoms or rising HbA1c (e.g >8.5%) –>Basal insulin or premixed insulin initially –>Add prandial insulin with time if required b. PBS: Thiazolidinedione (only pioglitazone is PBS listed), If no congestive heart failure-> acarbose, DPP4 inhibitor
Glucose monitoring targets
Targets for SMBG levels are 6–8 mmol/L fasting and pre-prandial, and 6–10 mmol/L 2 h postprandial